Type to search

Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages | Pharmtech Focus
Welsh Startup Antiverse Raises $2m for Antibody Discovery Toolkit | Pharmtech Focus
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials | Pharmtech Focus